What do I need to qualify for Wegovy?

Understanding the Legal Landscape of Telehealth Prescriptions for Weight Loss Medications

The popularity of GLP-1 agonists like Wegovy, Ozempic, and Mounjaro has exploded as effective options for managing obesity. As telehealth continues to grow, many patients wonder: ‘Can I legally get these weight loss medications through online appointments?’ The good news is that in most states, the answer is yes—but there are important nuances to understand depending on where you live.

Free consultations available with select providers only.

Get a free consultation

And find an affordable, caring specialist.

Find a provider

Free consultations available with select providers only.

Can You Get GLP-1 Weight Loss Medications Through Telehealth?

Yes, GLP-1 weight loss medications can legally be prescribed via telehealth in all 50 states. Since these medications are not controlled substances, they aren’t subject to the strict federal in-person requirements that apply to drugs like Adderall or opioids.

However, state regulations vary significantly, with some requiring an initial in-person visit while others fully embrace virtual care for these treatments. Understanding these differences is crucial if you’re considering telehealth for your weight management journey.

Why GLP-1s Can Be Prescribed Through Telehealth

GLP-1 agonists like semaglutide (Wegovy, Ozempic) and tirzepatide (Mounjaro, Zepbound) fall outside the Drug Enforcement Administration’s (DEA) scheduling system. This is important because:

• Non-controlled status: Unlike appetite suppressants such as phentermine, GLP-1s don’t face federal restrictions requiring in-person visits
• Clinical safety profile: These medications work through metabolic and appetite regulation rather than central nervous system stimulation
• Long-term treatment approach: They’re designed for ongoing weight management rather than short-term use

Dr. Sarah Chen, an endocrinologist at Klarity Health, explains: ‘Because GLP-1 medications aren’t controlled substances, federal law allows us to prescribe them via telehealth after a thorough virtual evaluation. This has been transformative for patients who previously couldn’t access obesity treatment due to geographic or mobility limitations.’

State-by-State Telehealth Regulations for Weight Loss Medications

While federal law permits telehealth prescribing of GLP-1s, state regulations create a patchwork of requirements across the country. Here’s what you need to know about key state differences:

States With Fully Telehealth-Friendly Approaches

These states allow complete telehealth prescribing with no mandatory in-person visits:

• California: Pioneered telehealth-friendly regulations; allows NPs to practice independently after gaining experience
• New York: Permits establishing patient relationships entirely via video visits
• Washington: One of the most progressive telehealth states with no in-person requirements
• Illinois: Permanent telehealth laws allow virtual prescribing without in-person visits

States Requiring Initial In-Person Exams

Some states maintain stricter oversight, requiring at least one face-to-face visit:

• Arkansas: Requires an initial in-person physical examination before telehealth can be used for ongoing treatment
• Georgia: Mandates that the first visit must be conducted in person before transitioning to virtual care
• Mississippi: State law requires an initial in-person evaluation specifically for weight management therapy
• South Carolina: Requires examining patients in person before prescribing weight loss medications

States With Special Documentation Requirements

Several states allow telehealth but impose specific protocols:

• Florida: Requires patients to have a BMI ≥30 and be seen at least once every three months
• New Jersey: Mandates comprehensive initial evaluation including lab work and a personalized diet/exercise plan
• Virginia: Requires initial physical exam, lab testing, and a follow-up within 30 days of starting therapy

Who Can Prescribe GLP-1 Medications via Telehealth?

Provider qualifications vary by state, which affects who can treat you through telehealth platforms:

Physicians (MDs and DOs)

Medical doctors and doctors of osteopathic medicine can prescribe GLP-1s via telehealth in all states (provided they’re licensed in the patient’s state).

Nurse Practitioners (NPs)

• Full Independence: In about half the states (including CA, NY, WA), NPs can prescribe independently
• Collaborative Practice: States like Texas, Florida, and Pennsylvania require physician oversight
• Restricted Practice: A few states maintain significant limitations on NP prescribing authority

Physician Assistants (PAs)

PAs can generally prescribe GLP-1 medications in all states but always require some form of physician supervision or collaboration.

Common Misconceptions About Telehealth Weight Loss Treatment

Despite their growing popularity, several misconceptions persist about obtaining GLP-1 medications through telehealth:

Misconception #1: ‘Anyone can get weight loss drugs online without proper screening’

Reality: Legitimate telehealth providers conduct thorough evaluations to ensure patients meet clinical criteria (typically BMI ≥30, or ≥27 with weight-related conditions).

Misconception #2: ‘Telehealth prescriptions aren’t as safe as in-person care’

Reality: Research shows that when properly implemented, telehealth weight management can achieve similar safety profiles and outcomes to in-person care.

Misconception #3: ‘Compounded versions of these medications are just as good’

Reality: The FDA banned most compounded semaglutide in May 2025 due to safety concerns. Legitimate providers prescribe only FDA-approved versions.

Misconception #4: ‘I can get these medications without ongoing monitoring’

Reality: Reputable telehealth services require regular follow-ups and may request periodic lab work to monitor your response and address side effects.

The Telehealth Evaluation Process for Weight Loss Medications

When seeking GLP-1 medications through a quality telehealth provider like Klarity Health, expect a comprehensive process:

1. Initial screening: Complete a detailed medical questionnaire covering weight history, previous attempts at weight loss, medical conditions, and current medications

2. Provider consultation: Meet virtually with a licensed healthcare provider who will:

• Review your medical history
• Discuss your weight management goals
• Evaluate whether medication is appropriate
• Explain potential benefits and risks
• Address your questions and concerns

1. Prescription decision: If medically appropriate, your provider will prescribe the most suitable GLP-1 medication

2. Medication delivery: Your prescription is sent electronically to your preferred pharmacy or may be available through mail-order options

3. Follow-up care: Regular telehealth check-ins (typically monthly at first, then every 2-3 months) to monitor progress, adjust dosage if needed, and manage any side effects

At Klarity Health, this process is streamlined with transparent pricing, insurance acceptance options, and provider availability that exceeds many traditional clinics—making weight management more accessible than ever.

Red Flags: How to Identify Questionable Telehealth Providers

Not all telehealth services follow ethical and legal standards. Be wary of providers that:

• Guarantee prescriptions without thorough medical evaluations
• Offer ‘compounded’ semaglutide following the FDA’s May 2025 ban
• Don’t verify your identity or request comprehensive medical information
• Skip discussions about potential risks and side effects
• Fail to create a comprehensive treatment plan beyond medication
• Don’t schedule regular follow-up appointments
• Lack transparency about provider credentials or state licensing
• Ship medications directly rather than through licensed pharmacies

Looking Ahead: The Future of Telehealth for Weight Loss Treatment

The regulatory landscape continues to evolve, but several trends are clear:

• Expanded access: More states are moving toward telehealth-friendly regulations as positive outcomes accumulate
• Regulatory standardization: We may see greater alignment of state policies to reduce geographic disparities in care
• Integration with in-person care: Hybrid models combining telehealth with occasional in-person visits may become the standard
• Technology advancements: Improved remote monitoring tools will enhance the telehealth experience for weight management

Conclusion: Making Informed Decisions About Telehealth Weight Loss Treatment

GLP-1 agonists represent a breakthrough in obesity medicine, and telehealth has made these treatments more accessible than ever. While telehealth prescribing of these medications is broadly legal, understanding your state’s specific requirements ensures you receive appropriate, compliant care.

When choosing a telehealth provider for weight loss medication, look for comprehensive evaluations, appropriate follow-up care, and transparent communication about what to expect. Providers like Klarity Health offer the convenience of telehealth with the thoroughness and oversight of traditional care—making effective weight management possible regardless of your location or schedule.

If you’re considering a GLP-1 medication for weight management, a reputable telehealth provider can determine if you’re a

Source:

• https://www.axios.com/2024/11/18/covid-telehealth-prescribing-extended-adderall#:~:text=The%20Drug%20Enforcement%20Administration%20,year%20extension
• https://www.dea.gov/documents/2024/2024-11/2024-11-15/dea-and-hhs-extend-telemedicine-flexibilities-through-2025#:~:text=telemedicine%20flexibilities%20through%20December%2031%2C,HHS%20on%20November%2015%2C%202024
• https://www.mwe.com/insights/dea-signals-extension-of-telemedicine-flexibilities-for-controlled-substance-prescribing-for-2026/#:~:text=A%20new%20rule%20posted%20on,date%20of%20December%2031%2C%202025
• https://www.mwe.com/insights/dea-extends-telemedicine-flexibilities-for-controlled-substance-prescribing-through-december-31-2025/#:~:text=,a%20final%20set%20of%20regulations
• https://www.mwe.com/insights/dea-extends-telemedicine-flexibilities-for-controlled-substance-prescribing-through-december-31-2025/#:~:text=31%2C%202024.%20,In%20February%202023%2C%20the%20DEA
• https://www.mwe.com/insights/dea-extends-telemedicine-flexibilities-for-controlled-substance-prescribing-through-december-31-2025/#:~:text=to%20perform%20an%20in,rule%20regarding%20telemedicine%20prescribing%20of
• https://www.whitehouse.senate.gov/news/release/whitehouse-murkowski-warner-blackburn-urge-white-house-and-dea-to-extend-telehealth-flexibilities-for-substance-use-disorder-and-mental-health-treatment/#:~:text=Whitehouse%2C%20Murkowski%2C%20Warner%2C%20Blackburn%20Urge,substance%20use%20disorder%20treatment%20Washington
• https://natlawreview.com/article/arkansas-it-again-telemedicine-regulation-arkansas-undergoes-additional-change#:~:text=Arkansas%20currently%20has%20one%20of,person%20examination
• https://www.nextech.com/blog/semaglutide-laws-by-state#:~:text=Who%20can%20prescribe%20semaglutide%3F%20,
• https://natlawreview.com/article/arkansas-it-again-telemedicine-regulation-arkansas-undergoes-additional-change#:~:text=Arkansas%20currently%20has%20one%20of,encounter%20to%20establish%20a%20valid